HomeBUSINESS
BUSINESS

Santen to Take Another Stab at US Market, Eyes Stand-Alone Sales Force
(May.15.2017)

Santen President Akira Kurokawa
Santen Pharmaceutical is making a renewed attempt to go into the US market, aiming to build a stand-alone sales force, to begin with, for the sirolimus intravitreal injection (DE-109), which is now under FDA review for non-infectious uveitis of the posterior segment ...
(LOG IN FOR FULL STORY)

News Calendar